Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shahre Darou Pharmaceutical (also known as Shahrdaru) is an Iranian pharmaceutical company established in 1964 that specializes in the formulation, research, and manufacturing of a wide range of human medicines, dietary supplements, and topical products. The company operates advanced manufacturing lines for oral solids (tablets, capsules, pellets), liquids (syrups, drops, suspensions), and topical formulations (shampoos, mouthwashes, and disinfectants). Its product portfolio includes over 130 pharmaceutical preparations spanning therapeutic areas such as cardiovascular health, gastroenterology, neurology, pain management, and dermatology. Shahre Darou is committed to national and international GMP standards, serving the domestic Iranian market and collaborating with international partners like Ethypharm.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shahrdaru Pharmaceutical.